Dr. Ziva Cooper, Human Studies Probing Cannabis Constitutents for Pain Relief: Looking Beyond Delta-9-THC

July 2021

Dr. Ziva Cooper is the Director of the UCLA Cannabis Research Initiative in the Jane and Terry Semel Institute for Neuroscience and Human Behavior and Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence both the therapeutic potential and adverse effects of cannabis and cannabinoids through double-blind, placebo-controlled studies.

Current funded projects include 1) understanding differences between men and women in their response to the abuse-related and pain-relieving effects, and the role that circulating hormones and endocannabinoids contribute to these differences, 2) the potential for THC and CBD to reduce reliance on opioids, 3) impact of cannabis use on HIV-associated inflammation, and 4) the effectiveness of cannabidiol to address symptoms associated with rheumatoid arthritis.

Dr. Cooper served on the National Academies of Sciences Committee on the Health Effects of Cannabis that recently published a comprehensive consensus report of the health effects of cannabis and cannabinoids. She is past president of the International Study Group Investigating Drugs as Reinforcers, a Board Director for the College on Problems of Drug Dependence, an Associate Editor of The American Journal of Drug and Alcohol Abuse, and is on several Editorial Boards of journals including Cannabis and Cannabinoid Research and Neuropsychopharmacology.

Previous Webinars

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

July 17th, 11:00AM MST

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Felipe Sarmiento Salazar, PhD

Flowering modulation in Cannabis sp. by night
interruption

June 19, 2024 11:00AM MT

Dr. Felipe Sarmiento Salazar is a biologist graduated from the Universidad de los Andes, doctor in Biology from the University of Freiburg and professor at the Department of Biology of the National University of Colombia since 2016. Professor Sarmiento has extensive experience in […]

Read More »

Ken Olejar, PhD

Cannabinoid extraction and modification: Current and future trends

May 15th, 11:00 AM MST

Dr Ken Olejar is a Research Associate at Colorado State University – Pueblo and the founder of AgriBioactive Consulting. He obtained his MSc in Pharmaceutical Science from the University of Florida and his PhD in Analytical Chemistry from The University of Auckland, New […]

Read More »

Ethan Russo, MD

Limonene, THC, Herbal Synergy and the Entourage Effect

June 13, 2024, 1:00PM MT

Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]

Read More »